Woodline Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.01M | Hold |
212,303
| – | – | 0.04% | 499 |
|
|
2025
Q1 | $8.53M | Buy |
212,303
+86,102
| +68% | +$3.46M | 0.06% | 390 |
|
|
2024
Q4 | $5.94M | Sell |
126,201
-2,834
| -2% | -$133K | 0.04% | 452 |
|
|
2024
Q3 | $6.81M | Sell |
129,035
-69,146
| -35% | -$3.65M | 0.06% | 347 |
|
|
2024
Q2 | $10.7M | Buy |
+198,181
| New | +$10.7M | 0.1% | 239 |
|
|
2024
Q1 | – | Sell |
-42,652
| Closed | -$3.56M | – | 558 |
|
|
2023
Q4 | $3.56M | Buy |
+42,652
| New | +$3.56M | 0.04% | 345 |
|